Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.
Level 1 - systematic review of randomized trials
Systematic review of 15 studies evaluating psilocybin's antidepressant mechanisms.
PubMed 39829391 · doi:10.1177/02698811241312866
What was done
A systematic review was conducted in accordance with PRISMA guidelines to examine the neurobiological and psychological antidepressant mechanisms of psilocybin. The authors synthesized findings from 15 studies investigating change principles including brain dynamics, emotion regulation, cognition, self-referential processing, connectedness, and interpersonal functioning.
What was found
The abstract reports no numerical data, effect sizes, or statistical metrics. Qualitatively, psilocybin within supportive settings was reported to promote openness, neural and cognitive flexibility, emotional acceptance, and a renewed sense of connectedness. Neuroimaging studies consistently showed altered brain dynamics featuring reduced global and within-default mode network connectivity alongside increased between-network connectivity.
Why it matters
It emphasizes that psilocybin's therapeutic efficacy likely emerges from an interplay between neurobiological network changes and psychotherapeutic support rather than isolated pharmacological action.
Limits
The abstract provides no quantitative data, effect sizes, or total participant numbers across the 15 included studies. Methodological details regarding study designs, risk of bias, control conditions, and specific clinical populations are not reported in the abstract.